These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4168588

  • 21. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM, Birkett DJ, Wade DN.
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [Abstract] [Full Text] [Related]

  • 22. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M, Hansen JM.
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract] [Full Text] [Related]

  • 23. Efect of "Dicumarol" (bishydroxycoumarin) on insulin secretion in vitro.
    Günther MA, López-Quijada C, Candela JL.
    Life Sci; 1966 Jun; 5(12):1091-5. PubMed ID: 4164320
    [No Abstract] [Full Text] [Related]

  • 24. The efficacy of oral tolbutamide in chronic alcoholics.
    Horowitz SH, Johnson BF.
    Am J Med Sci; 1972 Nov; 264(5):395-400. PubMed ID: 4650130
    [No Abstract] [Full Text] [Related]

  • 25. [Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents].
    Christensen LK, Kristensen M.
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():116-36. PubMed ID: 4190079
    [No Abstract] [Full Text] [Related]

  • 26. IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY.
    BURNS JJ.
    Am J Med; 1964 Sep; 37():327-31. PubMed ID: 14218162
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacogenetics of tolbutamide metabolism in humans.
    Scott J, Poffenbarger PL.
    Diabetes; 1979 Jan; 28(1):41-51. PubMed ID: 569611
    [Abstract] [Full Text] [Related]

  • 28. Evidence for an antithrombotic effect of Dicumarol.
    DEYKIN D, WESSLER S, REIMER SM.
    Am J Physiol; 1960 Dec; 199():1161-4. PubMed ID: 13722414
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Anti-inflammatory evaluation of cryogenine.
    Kaplan HR, Wolke RE, Malone MH.
    J Pharm Sci; 1967 Nov; 56(11):1385-92. PubMed ID: 6060584
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM, Miners JO.
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sulfamethizole-induced inhibition of diphenlhydantoin, tolbutamide, and warfarin metabolism.
    Lumholtz B, Siersbaek-Nielsen K, Skovsted L, Kampmann J, Hansen JM.
    Clin Pharmacol Ther; 1975 Jun; 17(6):731-4. PubMed ID: 1139863
    [Abstract] [Full Text] [Related]

  • 40. The anticoagulant response to bishydroxycoumarin. I. The role of individual variation.
    Solomon HM, Schrogie JJ.
    Clin Pharmacol Ther; 1967 Jun; 8(1):65-9. PubMed ID: 4163171
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.